false0000916540 0000916540 2020-05-05 2020-05-05


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
       
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported)
May 5, 2020

DARLING INGREDIENTS INC.
(Exact Name of Registrant as Specified in Charter)
 
Delaware
001-13323
36-2495346
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

5601 N. MacArthur Blvd., Irving, Texas 75038                    
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (972) 717-0300                

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock $0.01 par value per share
DAR
New York Stock Exchange
(“NYSE”)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


1



Item 5.07.
Submission of Matters to a Vote of Security Holders.

At the annual meeting of stockholders of Darling Ingredients Inc. (the "Company") held on May 5, 2020, the stockholders elected the Company's Board of Directors and voted upon two Board proposals contained within the Company's Proxy Statement dated March 25, 2020.

The Board nominees were elected with the following vote:

Nominee
For
Against
Abstentions
Broker Non-Votes
 
 
 
 
 
Randall C. Stuewe
140,507,193

7,182,257

157,829

3,841,224

Charles Adair
146,722,465

967,036

157,778

3,841,224

Beth Albright
147,306,139

382,904

158,236

3,841,224

Linda Goodspeed
146,754,358

934,990

157,931

3,841,224

Dirk Kloosterboer
147,209,316

437,516

200,447

3,841,224

Mary R. Korby
145,115,201

2,550,230

181,848

3,841,224

Charles Macaluso
137,073,104

10,612,949

161,226

3,841,224

Gary W. Mize
146,748,000

941,506

157,773

3,841,224

Michael E. Rescoe
147,209,500

437,182

200,597

3,841,224

Nicole M. Ringenberg
147,258,616

432,173

156,490

3,841,224


The stockholders voted on the following proposals and cast their votes as described below:

Board proposal to ratify the selection of KPMG LLP, independent registered public accounting firm, as the Company’s independent registered public accountant for the fiscal year ending January 2, 2021:

For
Against
Abstentions
Broker Non-Votes
145,976,985

5,533,370

178,148



Board proposal to approve, on an advisory basis, the Company’s executive compensation:

For
Against
Abstentions
Broker Non-Votes
145,061,293

2,604,837

181,149

3,841,224


Item 9.01.     Financial Statements and Exhibits. 

(d)           Exhibits.

104

 
Cover Page Interactive Data File (embedded within Inline XBRL document)


2



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  
 
 
DARLING INGREDIENTS INC.
 
 
 
 
 
Date:  May 7, 2020
By:
/s/ John F. Sterling
 
 
 
John F. Sterling
 
 
 
Executive Vice President,
General Counsel
 



3